135 related articles for article (PubMed ID: 23049623)
1. Programmed cell death 4 (Pdcd4) expression in colorectal adenocarcinoma: Association with clinical stage.
Lim SC; Hong R
Oncol Lett; 2011 Nov; 2(6):1053-1057. PubMed ID: 23049623
[TBL] [Abstract][Full Text] [Related]
2. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
[TBL] [Abstract][Full Text] [Related]
3. Programmed cell death 4 protein in esophageal cancer.
Fassan M; Cagol M; Pennelli G; Rizzetto C; Giacomelli L; Battaglia G; Zaninotto G; Ancona E; Ruol A; Rugge M
Oncol Rep; 2010 Jul; 24(1):135-9. PubMed ID: 20514454
[TBL] [Abstract][Full Text] [Related]
4. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma.
Reis PP; Tomenson M; Cervigne NK; Machado J; Jurisica I; Pintilie M; Sukhai MA; Perez-Ordonez B; Grénman R; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S
Mol Cancer; 2010 Sep; 9():238. PubMed ID: 20831814
[TBL] [Abstract][Full Text] [Related]
5. Low PDCD4 Expression Is Associated With Poor Prognosis of Colorectal Carcinoma.
Kim JY; Lee H; Kim EK; Lee WM; Hong YO; Hong SA
Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):685-692. PubMed ID: 34029220
[TBL] [Abstract][Full Text] [Related]
6. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.
Chen Y; Knösel T; Kristiansen G; Pietas A; Garber ME; Matsuhashi S; Ozaki I; Petersen I
J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601
[TBL] [Abstract][Full Text] [Related]
7. Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis.
Fassan M; Pizzi M; Battaglia G; Giacomelli L; Parente P; Bocus P; Ancona E; Rugge M
J Clin Pathol; 2010 Aug; 63(8):692-6. PubMed ID: 20702469
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
9. PDCD4 functions as a suppressor for pT2a and pT2b stage gastric cancer.
Guo PT; Yang D; Sun Z; Xu HM
Oncol Rep; 2013 Mar; 29(3):1007-12. PubMed ID: 23314309
[TBL] [Abstract][Full Text] [Related]
10. Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma.
Lin LJ; Chen LT
Mol Med Rep; 2013 Jul; 8(1):61-6. PubMed ID: 23708420
[TBL] [Abstract][Full Text] [Related]
11. Expression of tumor suppressor programmed cell death 4 in endometrioid endometrial carcinomas and clinicopathological significance.
Liu Y; Sun H; Mao H; Gao M; Tan X; Li Y; Li Y; Muloye GM; Zhang L; Wang X; Wei Z
Oncol Lett; 2018 Jun; 15(6):9369-9376. PubMed ID: 29805661
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer.
Motoyama K; Inoue H; Mimori K; Tanaka F; Kojima K; Uetake H; Sugihara K; Mori M
Int J Oncol; 2010 May; 36(5):1089-95. PubMed ID: 20372781
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of miR-21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection.
Zhang J; Ma L; Shi D; Zhang Z; Yao C; Zhao X; Xu Q; Wen P; He L
J Cell Biochem; 2018 Jun; 119(6):4783-4791. PubMed ID: 29331036
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers.
Kakimoto T; Shiraishi R; Iwakiri R; Fujimoto K; Takahashi H; Hamajima H; Mizuta T; Ideguchi H; Toda S; Kitajima Y; Ozaki I; Matsuhashi S
Oncol Rep; 2011 Dec; 26(6):1385-92. PubMed ID: 21894439
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic localization of programmed cell death 4 contributes to its anti-apoptotic function.
Takaki S; Eto K
Mol Cell Biochem; 2018 Nov; 448(1-2):155-164. PubMed ID: 29442268
[TBL] [Abstract][Full Text] [Related]
16. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients.
Li X; Xin S; Yang D; Li X; He Z; Che X; Wang J; Chen F; Wang X; Song X
J Cancer Res Clin Oncol; 2012 Mar; 138(3):529-35. PubMed ID: 22203471
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma.
Wang X; Wei Z; Gao F; Zhang X; Zhou C; Zhu F; Wang Q; Gao Q; Ma C; Sun W; Kong B; Zhang L
Anticancer Res; 2008; 28(5B):2991-6. PubMed ID: 19031945
[TBL] [Abstract][Full Text] [Related]
19. Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer.
Wei NA; Liu SS; Leung TH; Tam KF; Liao XY; Cheung AN; Chan KK; Ngan HY
Mol Cancer; 2009 Sep; 8():70. PubMed ID: 19728867
[TBL] [Abstract][Full Text] [Related]
20. PDCD4 as a predictor of sensitivity to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Dou X; Wang RB; Meng XJ; Yan HJ; Jiang SM; Zhu KL; Xu XQ; Chen D; Song XR; Mu DB
Asian Pac J Cancer Prev; 2014; 15(2):825-30. PubMed ID: 24568503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
